IEX •
Healthcare •
Biotechnology •
Quote as of 05/06/2026 15:58
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization1,352.32 mln
Float206 mln
Earnings Date05/11/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.28
Manipulation likely
1-Year Forecast
9.50
Transformational upside
Relative Strength
97
/ 100
Top performer
Debt / Equity
0.15
Very low leverage
ROE
-14.59
Negative
Business Description
AbCellera Biologics is a Canadian biotechnology company focused on finding and building new antibody-based treatments for patients who currently have few or no good options. The company has two drugs in clinical testing: one aimed at relieving hot flashes and night sweats without using hormones, and another designed to treat immune-related skin conditions like eczema. AbCellera works alongside several major pharmaceutical and investment partners, including Eli Lilly, AbbVie, and Biogen, and operates out of its headquarters in Vancouver, Canada.
